SS Innovations International SSII

NASDAQ SSII
$2.41 -0.13 (-5.12%)
At close: Oct 21, 2026 · 4:00 PM EDT

SS Innovations International (SSII) stock price is $2.41, down 5.12% on the day, as of Oct 21, 2026. It has a market cap of $478.33Mn, and is classified in the Medical Devices industry (Healthcare sector).

Key Stats
Market Cap478.33 Mn
P/E-38.47
P/S9.13
Div. Yield0.00
Total Debt (Qtr)14.63 Mn
Revenue Growth (1y) (Qtr)39.39
Add ratio to table…

About

SS Innovations International, Inc. is a commercial-stage surgical robotics company that designs manufactures and markets the SSi Mantra Surgical Robotic System for use in urology general gynecology colorectal gastroenterology head and neck thoracic and cardiac surgeries. The company was founded by Dr Sudhir P Srivastava and launched commercial sales of the SSi Mantra in India in late 2022 after receiving regulatory approval from the Central Drugs Standard Control…

Read more ↓
Sector: Healthcare Sector rationale The company designs, manufactures, and markets the SSi Mantra Surgical Robotic System, which is a medical device used for various surgical procedures. Its primary customers are hospitals and healthcare facilities, and its revenue is derived from the sale of these medical systems and related surgical instruments. Industries: Medical Devices Medical Devices Primary The company designs, manufactures, and markets the SSi Mantra Surgical Robotic System, which is used for various surgical procedures including urology and cardiac surgeries. Its revenue is derived from the sale of these surgical robots and related instruments. Medical Supplies Medical Supplies Secondary The company generates recurring revenue from the sale of instruments and accessories used with its robotic systems, which are medical consumables/supplies. Classified using BQ-MICS CIK: 0001676163

Geographical Breakdown of Revenue (2025)

History

Product and Service Breakdown of Revenue (2025)

History
Peer percentiles

How SS Innovations International ranks

Ranked against the 248 companies in Medical Devices and Diagnostics58 metrics · as of Oct 21, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/ENegative earnings −40.9xMedian 29.6x 61st
  • P/FCFNegative free cash flow −27.9xMedian 24.3x 49th
  • P/Operating cash flowNegative operating cash flow −32.7xMedian 19.8x 48th
  • P/S 9.70xMedian 3.05x 19th
  • P/B 9.52xMedian 2.40x 11th
  • P/Tangible book 9.52xMedian 3.02x 13th
  • EV/EBITDANegative EBITDA −70.7xMedian 17.8x 50th
  • EV/EBITNegative EBIT −60.1xMedian 27.8x 57th
  • EV/Revenue 9.72xMedian 3.22x 15th
  • EV/FCFNegative free cash flow −28.0xMedian 27.0x 43rd
  • EV/Operating cash flowNegative operating cash flow −32.8xMedian 21.4x 41st
  • PEG (3Y EPS CAGR)Negative earnings 3.97Median 0.95 Not meaningful —
Peer group

Peer Comparison

Companies in the Medical Devices
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 257.99 Bn37.035.5742.55 Bn
2 ABT Abbott Laboratories 175.01 Bn32.263.7632.61 Bn
3 DHR Danaher Corp /De/ 164.93 Bn41.196.5726.56 Bn
4 ISRG Intuitive Surgical Inc 151.84 Bn48.3713.76-
5 MDT Medtronic plc 119.05 Bn22.763.1728.15 Bn
6 SYK Stryker Corp 113.89 Bn30.544.4114.94 Bn
7 BSX Boston Scientific Corp 65.37 Bn17.793.1112.62 Bn
8 SSII SS Innovations International, Inc. 0.48 Bn-38.479.130.01 Bn